SEC Comment Letter for PULSE BIOSCIENCES, INC. (PLSE) (CIK 0001625101) (PLSE) — Sep 11, 2019

PULSE BIOSCIENCES, INC. (PLSE) (CIK 0001625101)
Date: Sept. 11, 2019 · CIK: 0001625101 · Accession: 0000000000-19-013460

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-37744

Date

September 11, 2019

Author

Brian Dow

Form

UPLOAD

Company

PULSE BIOSCIENCES, INC. (PLSE) (CIK 0001625101)

Letter

September 11, 2019 Brian Dow Chief Financial Officer Pulse Biosciences, Inc. 3957 Point Eden Way Hayward, CA 94545 Re:Pulse Biosciences, Inc. Form 10-K for the Year Ended December 31, 2018 Filed March 14, 2019 File No. 001-37744 Dear Mr. Dow: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Electronics and Machinery

Show Raw Text

September 11, 2019
Brian Dow
Chief Financial Officer
Pulse Biosciences, Inc.
3957 Point Eden Way
Hayward, CA 94545
Re:Pulse Biosciences, Inc.
Form 10-K for the Year Ended December 31, 2018
Filed March 14, 2019
File No. 001-37744
Dear Mr. Dow:
            We have completed our review of your filings.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery

SecProbe.io